380 related articles for article (PubMed ID: 24117955)
1. Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy.
Levy JH; Welsby I; Goodnough LT
Transfusion; 2014 May; 54(5):1389-405; quiz 1388. PubMed ID: 24117955
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding.
Levy JH; Szlam F; Tanaka KA; Sniecienski RM
Anesth Analg; 2012 Feb; 114(2):261-74. PubMed ID: 21965371
[TBL] [Abstract][Full Text] [Related]
3. Severe bleeding in surgical and trauma patients: the role of fibrinogen replacement therapy.
Spahn DR
Thromb Res; 2012 Dec; 130 Suppl 2():S15-9. PubMed ID: 23439002
[TBL] [Abstract][Full Text] [Related]
4. Observational study of fibrinogen concentrate in massive hemorrhage: evaluation of a multicenter register.
Weiss G; Lison S; Glaser M; Herberger S; Johanning K; Strasser T; Huber T; Spannagl M; Heindl B
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):727-34. PubMed ID: 22024795
[TBL] [Abstract][Full Text] [Related]
5. Restoring hemostasis: fibrinogen concentrate versus cryoprecipitate.
Elliott BM; Aledort LM
Expert Rev Hematol; 2013 Jun; 6(3):277-86. PubMed ID: 23782082
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial.
Rahe-Meyer N; Hanke A; Schmidt DS; Hagl C; Pichlmaier M
J Thorac Cardiovasc Surg; 2013 Mar; 145(3 Suppl):S178-85. PubMed ID: 23410777
[TBL] [Abstract][Full Text] [Related]
7. [Required laboratory examination and blood transfusion therapy in massive hemorrhage during surgery].
Yamamoto K
Rinsho Byori; 2011 Jul; 59(7):678-83. PubMed ID: 21874794
[TBL] [Abstract][Full Text] [Related]
8. How I use fibrinogen replacement therapy in acquired bleeding.
Levy JH; Goodnough LT
Blood; 2015 Feb; 125(9):1387-93. PubMed ID: 25519751
[TBL] [Abstract][Full Text] [Related]
9. In vitro efficacy of RiaSTAP after rapid reconstitution.
Karri JV; Cardenas JC; Johansson PI; Matijevic N; Cotton BA; Wade CE; Holcomb JB
J Surg Res; 2014 Aug; 190(2):655-61. PubMed ID: 24602482
[TBL] [Abstract][Full Text] [Related]
10. Fibrinogen Supplementation and Its Indications.
Grottke O; Mallaiah S; Karkouti K; Saner F; Haas T
Semin Thromb Hemost; 2020 Feb; 46(1):38-49. PubMed ID: 31574543
[TBL] [Abstract][Full Text] [Related]
11. Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial.
Galas FR; de Almeida JP; Fukushima JT; Vincent JL; Osawa EA; Zeferino S; Câmara L; Guimarães VA; Jatene MB; Hajjar LA
J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1647-55. PubMed ID: 24951020
[TBL] [Abstract][Full Text] [Related]
12. The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding.
Fries D
Transfusion; 2013 Jan; 53 Suppl 1():91S-95S. PubMed ID: 23301979
[TBL] [Abstract][Full Text] [Related]
13. Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery.
Rahe-Meyer N; Solomon C; Winterhalter M; Piepenbrock S; Tanaka K; Haverich A; Pichlmaier M
J Thorac Cardiovasc Surg; 2009 Sep; 138(3):694-702. PubMed ID: 19698858
[TBL] [Abstract][Full Text] [Related]
14. Severe pediatric blunt trauma--successful ROTEM-guided hemostatic therapy with fibrinogen concentrate and no administration of fresh frozen plasma or platelets.
Ziegler B; Schimke C; Marchet P; Stögermüller B; Schöchl H; Solomon C
Clin Appl Thromb Hemost; 2013; 19(4):453-9. PubMed ID: 22964782
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen Early In Severe Trauma studY (FEISTY): study protocol for a randomised controlled trial.
Winearls J; Wullschleger M; Wake E; Hurn C; Furyk J; Ryan G; Trout M; Walsham J; Holley A; Cohen J; Shuttleworth M; Dyer W; Keijzers G; Fraser JF; Presneill J; Campbell D
Trials; 2017 May; 18(1):241. PubMed ID: 28549445
[TBL] [Abstract][Full Text] [Related]
16. A critical evaluation of cryoprecipitate for replacement of fibrinogen.
Sørensen B; Bevan D
Br J Haematol; 2010 Jun; 149(6):834-43. PubMed ID: 20456356
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen concentrate in the treatment of severe bleeding after aortic aneurysm graft surgery.
Rahe-Meyer N
Thromb Res; 2011; 128 Suppl 1():S17-9. PubMed ID: 22221846
[TBL] [Abstract][Full Text] [Related]
18. Early fibrinogen concentrate therapy for major haemorrhage in trauma (E-FIT 1): results from a UK multi-centre, randomised, double blind, placebo-controlled pilot trial.
Curry N; Foley C; Wong H; Mora A; Curnow E; Zarankaite A; Hodge R; Hopkins V; Deary A; Ray J; Moss P; Reed MJ; Kellett S; Davenport R; Stanworth S
Crit Care; 2018 Jun; 22(1):164. PubMed ID: 29914530
[TBL] [Abstract][Full Text] [Related]
19. Comparing efficacy and safety of fibrinogen concentrate to cryoprecipitate in bleeding patients: a systematic review.
Jensen NH; Stensballe J; Afshari A
Acta Anaesthesiol Scand; 2016 Sep; 60(8):1033-42. PubMed ID: 27109179
[TBL] [Abstract][Full Text] [Related]
20. Protocol for a phase III, non-inferiority, randomised comparison of a new fibrinogen concentrate versus cryoprecipitate for treating acquired hypofibrinogenaemia in bleeding cardiac surgical patients: the FIBRES trial.
Karkouti K; Callum J; Rao V; Heddle N; Farkouh ME; Crowther MA; Scales DC
BMJ Open; 2018 Apr; 8(4):e020741. PubMed ID: 29678987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
